Gate Neurosciences
PrivateLast Round
M&A
May 27, 2025
Total Funding Raised
$58.9M
Company Overview
Gate Neurosciences is a biotechnology company that develops precision medicines to treat central nervous system disorders by enhancing synaptic function and neuroplasticity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gate Neurosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Gate Neurosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 27, 2025 | ||||
| Convertible Debt | Dec 31, 2024 | ||||
| Convertible Debt | Sep 30, 2022 | ||||
| Convertible Debt | Nov 24, 2021 |
Gate Neurosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioCrossroads | Convertible Debt, Seed |
| Luson BioVentures | Convertible Debt, M&A |
| Innoviva | Convertible Debt, M&A |
| Catalio Capital Management | M&A |
| M Capital | M&A |
| PagodaTree Partners | M&A |
| Tenmile | M&A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2025
$62M round led by Innoviva and Catalio Capital Management.
Gate Neurosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gate Neurosciences's valuation, stock price, and market status.